Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abgent is an established manufacturer of antibody reagents for research use with a comprehensive catalog of approximately 20,000 antibody products. The company has gained recognition through more than 1,100 peer-reviewed publications citing its products. As a commercial entity, Abgent supplies biological research reagents to academic, biotechnological, and pharmaceutical industries worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Abgent.